These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20088881)

  • 1. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
    Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
    FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
    Lee JO; Russo AA; Pavletich NP
    Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target.
    Chemes LB; Sánchez IE; de Prat-Gay G
    J Mol Biol; 2011 Sep; 412(2):267-84. PubMed ID: 21787785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal module of HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition plasticity to the oncoprotein.
    García-Alai MM; Alonso LG; de Prat-Gay G
    Biochemistry; 2007 Sep; 46(37):10405-12. PubMed ID: 17715947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human papillomavirus E7-E2 interaction mechanism in vitro reveals a finely tuned system for modulating available E7 and E2 proteins.
    Smal C; Wetzler DE; Dantur KI; Chemes LB; Garcia-Alai MM; Dellarole M; Alonso LG; Gaston K; de Prat-Gay G
    Biochemistry; 2009 Dec; 48(50):11939-49. PubMed ID: 19899811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
    Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
    Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
    Alunni-Fabbroni M; Littlewood T; Deleu L; Caldeira S; Giarrè M; Dell' Orco M; Tommasino M
    Oncogene; 2000 May; 19(19):2277-85. PubMed ID: 10822378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
    Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
    Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
    Uversky VN; Roman A; Oldfield CJ; Dunker AK
    J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Banks L; Edmonds C; Vousden KH
    Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone holdase activity of human papillomavirus E7 oncoprotein.
    Alonso LG; Smal C; Garcia-Alai MM; Chemes L; Salame M; de Prat-Gay G
    Biochemistry; 2006 Jan; 45(3):657-67. PubMed ID: 16411741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.
    Jones DL; Thompson DA; Münger K
    Virology; 1997 Dec; 239(1):97-107. PubMed ID: 9426450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
    Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of His-tagged HPV16 E7 protein active in pRb binding.
    Mirecka EA; Rudolph R; Hey T
    Protein Expr Purif; 2006 Aug; 48(2):281-91. PubMed ID: 16814565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
    Firzlaff JM; Galloway DA; Eisenman RN; Lüscher B
    New Biol; 1989 Oct; 1(1):44-53. PubMed ID: 2562189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.